These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26520895)

  • 1. Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease.
    Imhof A; Koenig W; Jaensch A; Mons U; Brenner H; Rothenbacher D
    Atherosclerosis; 2015 Dec; 243(2):414-20. PubMed ID: 26520895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of natural IgM antibodies against phosphorylcholine are independently associated with vascular remodeling in patients with coronary artery disease.
    Gleissner CA; Erbel C; Haeussler J; Akhavanpoor M; Domschke G; Linden F; Doesch AO; Conradson G; Buss SJ; Hofmann NP; Gitsioudis G; Katus HA; Korosoglou G
    Clin Res Cardiol; 2015 Jan; 104(1):13-22. PubMed ID: 25103819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes.
    Caidahl K; Hartford M; Karlsson T; Herlitz J; Pettersson K; de Faire U; Frostegård J
    Int J Cardiol; 2013 Jul; 167(2):464-9. PubMed ID: 22305633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome.
    Knudsen EC; Seljeflot I; Aksnes TA; Eritsland J; Arnesen H; Andersen GØ
    PLoS One; 2019; 14(4):e0215640. PubMed ID: 31002684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
    Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden.
    Grönlund H; Hallmans G; Jansson JH; Boman K; Wikström M; de Faire U; Frostegård J
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):382-6. PubMed ID: 19369878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low levels of a natural IgM antibody are associated with vein graft stenosis and failure.
    Sobel M; Moreno KI; Yagi M; Kohler TR; Tang GL; Clowes AW; Zhou XH; Eugenio E
    J Vasc Surg; 2013 Oct; 58(4):997-1005.e1-2. PubMed ID: 23856610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism.
    de Faire U; Su J; Hua X; Frostegård A; Halldin M; Hellenius ML; Wikström M; Dahlbom I; Grönlund H; Frostegård J
    J Autoimmun; 2010 Mar; 34(2):73-9. PubMed ID: 19726160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis.
    Carrero JJ; Hua X; Stenvinkel P; Qureshi AR; Heimbürger O; Bárány P; Lindholm B; Frostegård J
    Nephrol Dial Transplant; 2009 Nov; 24(11):3454-60. PubMed ID: 19549697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction.
    Rubini Gimenez M; Pagano S; Virzi J; Montecucco F; Twerenbold R; Reichlin T; Wildi K; Grueter D; Jaeger C; Haaf P; Vuilleumier N; Mueller C
    Eur J Clin Invest; 2015 Apr; 45(4):369-79. PubMed ID: 25627775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
    Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events.
    Ajeganova S; Andersson MLE; Frostegård J; Hafström I
    Arthritis Res Ther; 2021 Jul; 23(1):201. PubMed ID: 34311770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of one-year course of symptoms of anxiety and depression in patients with coronary heart disease: Role of physical activity and unmet medical need.
    Rothenbacher D; Jaensch A; Mons U; Hahmann H; Becker T; Koenig W; Brenner H
    Eur J Prev Cardiol; 2015 Sep; 22(9):1129-38. PubMed ID: 25070785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with polycystic ovary syndrome have lower levels of IgM anti-phosphorylcholine antibodies than healthy women.
    Gingnell M; Dahlbom I; Lindholm A; Hudecova M; Arnadottir R; Hansson T; Sundstrom-Poromaa I
    Gynecol Endocrinol; 2011 Jul; 27(7):486-90. PubMed ID: 20645890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction.
    Keller PF; Pagano S; Roux-Lombard P; Sigaud P; Rutschmann OT; Mach F; Hochstrasser D; Vuilleumier N
    J Intern Med; 2012 May; 271(5):451-62. PubMed ID: 22061093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D; Koenig W; Brenner H
    Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; Benavente L; Caminal-Montero L; Suárez A
    Rheumatology (Oxford); 2020 Feb; 59(2):407-417. PubMed ID: 31302689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low levels of IgM antibodies against phosphorylcholine are associated with fast carotid intima media thickness progression and cardiovascular risk in men.
    Gigante B; Leander K; Vikström M; Baldassarre D; Veglia F; Strawbridge RJ; McLeod O; Gertow K; Sennblad B; Shah S; Zabaneh D; Humphries SE; Kauhanen J; Rauramaa R; Smit AJ; Mannarino E; Giral P; Tremoli E; Hamsten A; Frostegård J; de Faire U;
    Atherosclerosis; 2014 Oct; 236(2):394-9. PubMed ID: 25150937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men.
    Sjöberg BG; Su J; Dahlbom I; Grönlund H; Wikström M; Hedblad B; Berglund G; de Faire U; Frostegård J
    Atherosclerosis; 2009 Apr; 203(2):528-32. PubMed ID: 18809177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms of anxiety and depression in patients with stable coronary heart disease: prognostic value and consideration of pathogenetic links.
    Rothenbacher D; Hahmann H; Wüsten B; Koenig W; Brenner H
    Eur J Cardiovasc Prev Rehabil; 2007 Aug; 14(4):547-54. PubMed ID: 17667646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.